Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02194959 · ClinicalTrials.gov registry record · NA

Peer Patient Navigation for Colon Cancer Screening

A NA study, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
800
Enrollment target

NCT02194959 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 800 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02194959, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
800 participants
Enrollment target

Study Summary

Cancer health disparities related to race and ethnicity are among the most serious problems facing the US health care system. A recent institute of medicine report stated that such disparities are seen at every level of health care, from prevention to treatment and follow-up. This problem is acutely evident in the figures for colorectal cancer (CRC) among African Americans. According to the American cancer society, African Americans have the highest CRC incidence and mortality of any ethnic/racial group. Indeed, CRC incidence and mortality are 15% and 43% higher among African Americans than whites, respectively. These disparities could be effectively reduced through greater African American participation in CRC screening and early detection. More importantly, due to the preponderance of CRC in African Americans beyond the reach of the flexible sigmoidoscopy (1), increased adherence to colonoscopy among African Americans will save lives. Although there is clear evidence that providing patients with someone to help them manage/navigate the health care system (i.e., patient navigation (PN)) is effective in helping them to complete cancer screening, very few hospitals provide PN for colonoscopy. The vast majority of hospitals in NYC are unable to provide PN for patients for whom colonoscopy is recommended, in large part because of the costs associated with professional-led PN. This project seeks to address this serious public health problem by investigating the success of training African Americans who have undergone colonoscopy to serve as volunteer peer patient navigators to encourage others from their community to complete CRC screening via colonoscopy.

Interventions

  • BEHAVIORAL Peer PN
  • BEHAVIORAL Pro PN

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2011-07
Est. Completion 2011-12
Phase NA

What the Registry Record Tells You About NCT02194959

The ClinicalTrials.gov registry entry for NCT02194959 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Peer PN is the first listed.

NCT02194959 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02194959 about?

NCT02194959 is a clinical study titled "Peer Patient Navigation for Colon Cancer Screening". Cancer health disparities related to race and ethnicity are among the most serious problems facing the US health care system. A recent institute of medicine report stated that such disparities are seen at every level of health care, from prevention to treatment and follow-up. This problem is acutely...

What is the current status of trial NCT02194959?

This trial is currently completed. It is a NA study. The enrollment target is 800 participants. The study started on 2011-07. Estimated completion is 2011-12.

What interventions are being tested in trial NCT02194959?

The interventions under investigation include: Peer PN (BEHAVIORAL), Pro PN (BEHAVIORAL).

Who is sponsoring clinical trial NCT02194959?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.